NBGH

House to Vote for Repeal of ACA’s ‘Cadillac Tax’
Risk & Compliance

House to Vote for Repeal of ACA’s ‘Cadillac Tax’

Despite strong bipartisan support for a repeal of the onerous excise tax on health benefits, its fate in the Senate remains unclear.
By David McCann | July 17, 2019
Read More
How to Rein In the Soaring Costs of Specialty Drugs
Risk & Compliance

How to Rein In the Soaring Costs of Specialty Drugs

The 420-employer National Business Group on Health recommends public-policy changes relating to the proliferating category of specialty drugs.
By David McCann | January 30, 2017
Read More
Specialty Drugs Drive Health Care Cost Trend
Human Capital & Careers

Specialty Drugs Drive Health Care Cost Trend

Health benefits costs are forecast to climb 5% next year, thanks in part to fast-rising prices for specialty pharmaceuticals.
By David McCann | August 9, 2016
Read More
Two-Year Delay for Obamacare’s Cadillac Tax Likely
Tax

Two-Year Delay for Obamacare’s Cadillac Tax Likely

A proposal to postpone the despised excise tax is an 11th-hour inclusion in the federal budget bill.
By David McCann | December 16, 2015
Read More
Rallying Against the Cadillac Tax
Human Capital & Careers

Rallying Against the Cadillac Tax

Companies, unions, and politicians on both sides of the aisle seek to repeal the coming excise tax on high-cost health plans.
By David McCann | December 15, 2015
Read More
Health-Care Cost Hikes Stay Modest for Big Companies
Human Capital & Careers

Health-Care Cost Hikes Stay Modest for Big Companies

The average company with more than 1,000 employees will pay 4.4 percent more in 2014 than it did last year, new research says.
By David McCann | March 7, 2014
Read More